Literature DB >> 1885263

Body mass index and patterns of mortality among Seventh-day Adventist men.

K Lindsted1, S Tonstad, J W Kuzma.   

Abstract

This study examines the relationship between body mass index (BMI) and 26-year mortality among 8828 nonsmoking, nondrinking Seventh-day Adventist men, including 439 who were very lean (BMI less than 20 kg/m2). The adjusted relative risk comparing the lowest BMI quintile (less than 22.3) to the highest (greater than 27.5 kg/m2) was 0.70 (95 percent CI 0.63-0.78) for all cause mortality, 0.60 (95 percent CI 0.43-0.85) for cerebrovascular mortality, and 0.80 (95 percent CI 0.61-1.04) for cancer mortality. Very lean men did not show increased mortality. To assess whether the protective effect associated with low BMI is modified by increasing age, the product term between BMI and attained age (age at the end of follow-up or at death) was included as a time-dependent covariate. For ischemic heart disease mortality, age-specific estimates of the relative risk for the lowest quintile relative to the highest ranged from 0.32 (95 percent CI, 0.19-0.52) at age 50 to 0.71 (95 percent CI, 0.56-0.89) at age 90. Interaction was also seen for the next lowest quintile (22.4-24.2). There was a significant trend of increasing mortality with increasing BMI for all endpoints studied. For cancer and cerebrovascular mortality the P-values for trend were 0.0001 and 0.001 respectively. For the other endpoints the P-values were less than 0.0001. Thus, there was no evidence for a J-shaped relationship between BMI and mortality in males. While the protective effect associated with the lowest BMI quintile decreased with increasing age for ischemic heart disease mortality, it remained greater than one at all ages. The relatively large number of subjects who were lean by choice, rather than as a result of preclinical disease or smoking, may explain these findings.

Entities:  

Mesh:

Year:  1991        PMID: 1885263

Source DB:  PubMed          Journal:  Int J Obes


  14 in total

1.  Is attainment of greater height and body size really desirable?

Authors:  T T Samaras; H Elrick; L H Storms
Journal:  J Natl Med Assoc       Date:  1999-06       Impact factor: 1.798

2.  Body mass index and the incidence of visually significant age-related maculopathy in men.

Authors:  D A Schaumberg; W G Christen; S E Hankinson; R J Glynn
Journal:  Arch Ophthalmol       Date:  2001-09

3.  Psychiatric symptoms in adolescence as predictors of obesity in early adulthood: a longitudinal study.

Authors:  D S Pine; P Cohen; J Brook; J D Coplan
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

Review 4.  Causes, diagnosis and risks of obesity.

Authors:  L Lissner
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

5.  Body size and mortality in women: a 29 year follow up of 12,000 pregnant women in northern Finland.

Authors:  E Läärä; P Rantakallio
Journal:  J Epidemiol Community Health       Date:  1996-08       Impact factor: 3.710

6.  Exercise in aging: its important role in mortality, obesity and insulin resistance.

Authors:  Alice S Ryan
Journal:  Aging health       Date:  2010-10

7.  Dietary determinants of ischaemic heart disease in health conscious individuals.

Authors:  J I Mann; P N Appleby; T J Key; M Thorogood
Journal:  Heart       Date:  1997-11       Impact factor: 5.994

8.  Trends in body mass index and prevalence of obesity in Swedish men 1980-89.

Authors:  A Kuskowska-Wolk; R Bergström
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

9.  [Health promotion and cardiovascular risk factors. The level of knowledge among 510 inpatients of an acute coronary care unit].

Authors:  H T Baberg; D Jäger; G Kahrmann; J de Zeeuw; W Bojara; B Lemke; S von Dryander; J Barmeyer; J Kugler
Journal:  Med Klin (Munich)       Date:  2000-02-15

10.  Examining the dynamic association of BMI and mortality in the Framingham Heart Study.

Authors:  Jianghua He; Daniel McGee; Xufeng Niu; Won Choi
Journal:  Int J Environ Res Public Health       Date:  2009-12-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.